These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25539042)

  • 1. Topiramate improves psychiatric symptoms in a patient with Lewy body dementia.
    Ochoa JG
    Cogn Behav Neurol; 2014 Dec; 27(4):222-3. PubMed ID: 25539042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Scheepmaker AJ; Horstink MW; Hoefnagels WH; Strijks FE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):32-5. PubMed ID: 12564296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case study in the treatment of dementia with Lewy bodies.
    Kaufer DI
    Acta Psychiatr Scand; 2004 Jul; 110(1):73-5; discussion 75-6. PubMed ID: 15180783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
    Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
    World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
    Cummings JL; Street J; Masterman D; Clark WS
    Dement Geriatr Cogn Disord; 2002; 13(2):67-73. PubMed ID: 11844887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
    Pinheiro D
    Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinations and comorbid renal tubular acidosis caused by topiramate in a patient with psychiatric history.
    Cheng M; Wen S; Tang X; Zhong Z
    Gen Hosp Psychiatry; 2013; 35(2):213.e1-3. PubMed ID: 22657836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine.
    Ridha BH; Josephs KA; Rossor MN
    Neurology; 2005 Aug; 65(3):481-2. PubMed ID: 16087923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.
    Narula PK; Rehan HS; Unni KE; Gupta N
    Schizophr Res; 2010 May; 118(1-3):218-23. PubMed ID: 20207521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain.
    Ko YH; Joe SH; Jung IK; Kim SH
    Clin Neuropharmacol; 2005; 28(4):169-75. PubMed ID: 16062095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature.
    Register SL; Ruano OL; Sanchez DL; Catalano G; Catalano MC
    Curr Drug Saf; 2017; 12(3):193-197. PubMed ID: 28699493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
    Rudolf J; Ghaemi M; Schmülling S
    Eur Psychiatry; 1999 Oct; 14(6):356-7. PubMed ID: 10572371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
    Suzuki H; Gen K; Takahashi Y
    Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A; Pani A
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.